dihydrochalcone has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, H; Choi, S; Han, DC; Jeon, YJ; Jung, SN; Kwon, BM; Lee, CW; Lee, J; Nash, O; Yun, J | 1 |
| Czuba, ZP; Krol, W; Mazur, B; Paradysz, A; Szliszka, E | 1 |
2 other study(ies) available for dihydrochalcone and Prostatic Neoplasms
| Article | Year |
|---|---|
Artocarpus altilis (Parkinson) Fosberg Extracts and Geranyl Dihydrochalcone Inhibit STAT3 Activity in Prostate Cancer DU145 Cells.
Topics: Animals; Apoptosis; Artocarpus; Caspase 3; Cell Line, Tumor; Chalcones; Female; Humans; Male; Mice, Inbred BALB C; Phosphorylation; Plant Extracts; Plant Leaves; Prostatic Neoplasms; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2015 |
Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Chalcones; Drug Synergism; Humans; Male; Membrane Potential, Mitochondrial; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand | 2010 |